AP
About
Astellas Venture Management (AVM) is the corporate venture capital arm of Astellas Pharma, Inc. AVM supports early-stage biotechnology companies focused on therapeutics programs and platform technologies for drug discovery and development. Their investment strategy aims to enhance Astellas' R&D pipeline or catalyze new directions in discovery research, acting as a strategic investor and potential liaison for future collaborations.
Sector Focus
["Biotechnology","Drug Discovery","Therapeutics","Health Care","Genetics","Medical Device","Life Science","Pharmaceutical","Biopharma"]
Series Focus
["Seed","Early Stage","Pre-Seed"]
Cheque Size
$19.0M - $19.0M
Score Breakdown
19Deal Activity
5Track Record
0Visibility
10Profile
75Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What type of investor is Astellas Pharma?
Astellas Venture Management (AVM) is the corporate venture capital arm of Astellas Pharma, Inc. AVM supports early-stage biotechnology companies focused on therapeutics programs and platform technologies for drug discovery and development. Their investment strategy aims to enhance Astellas' R&D pipeline or catalyze new directions in discovery research, acting as a strategic investor and potential…
Where is Astellas Pharma based?
Astellas Pharma is based in Brisbane, USA.
What sectors does Astellas Pharma focus on?
Astellas Pharma focuses on ["Biotechnology","Drug Discovery","Therapeutics","Health Care","Genetics","Medical Device","Life Science","Pharmaceutical","Biopharma"].
Similar Investors